NTUH developing promising nasal spray vaccine to combat Delta variant

11/23/2021 10:49 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

Taipei, Nov. 23 (CNA) A National Taiwan University Hospital (NTUH) research team announced on Tuesday that a COVID-19 nasal spray vaccine currently under development that targets the Delta variant has shown promising initial results following tests on mice.


(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

    We value your privacy.
    Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.